June 1, 2007
Oncology.

Anti-HER2/neu Therapy for Metastatic Breast Cancer

Supported by an educational grant from
Genentech

2 AMA PRA Category 1 Credit(s)™

EDITORS: Clifford Hudis, MD
Chief, Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center

Chau Dang, MD
Clinical Assistant Physician
Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center

AUTHOR: Chau Dang, MD

Article Tools